2006 proposed fee schedule - American Society of Clinical Oncology

383
25. The heading for Part 426 is revised to read as set
forth above.
Subpart C--General Provisions for the Review of LCDs and
NCDs
26. Section 426.340 is amended by –-
A. Revising paragraph (e)(2).
B. Adding paragraph (e)(3).
C. Revising paragraph (f)(2).
D. Adding paragraph (f)(3).
The revisions and additions read as follows:
§426.340 Procedures for review of new evidence.
* * * * *
(e) * * *
(2) For LCDs, sets a reasonable timeframe, not more
than 90 days, by which the contractor completes the
reconsideration.
(3) For NCDs, sets a reasonable timeframe, in
compliance with the timeframes specified in section 1862(1)
of the Act, by which CMS completes the reconsideration.
not met.
(f) * * *
(2) For LCDs, the 90-day reconsideration timeframe is
(3) For NCDs, the reconsideration timeframe as
specified by the Board, in compliance with section 1862(1)
of the Act, is not met.